Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions. 

 

View research grants awarded by year.
image of Jacob Montgomery
Jacob Montgomery, PhD
Investigation of Serotonergic Signaling Mechanisms that Promote Regeneration Following Spinal Cord Injury
Spinal cord injury often leads to loss of function below the injury, greatly reducing patient life expectancy and quality and, because the human…
2019-2021
image of Mi-Hyeon Jang, PhD
Mi-Hyeon Jang, PhD
Targeting Adenosine A2A Receptor as a Novel Regenerative Therapy in Improving Chemobrain
In the United States, cognitive dysfunction stemming from chemotherapy (chemobrain) is a major adverse condition affecting approximately 14 million…
2019-2021
image of Wenqian Hu, PhD
Wenqian Hu, PhD
Killing Cancer Cells by Activating the Cellular Intrinsic Nuclear Loss Program
A major problem in leukemia treatment is the rise of drug-resistant mutations in the genome of cancer cells, which makes many well-designed cancer…
2019-2021
image of Leigh Griffiths, DVM, PhD
Leigh Griffiths, DVM, PhD
Saphenous Vein Extracellular Matrix Scaffolds for Use in Coronary Artery Bypass
Minnesota Department of Health statistics indicate that almost 100,000 Minnesotan’s are currently affected by ischemic heart disease (IHD),…
2019-2021
image of Jonathan Finnoff, DO
Jonathan Finnoff, DO
Protein Removal and Purification of Platelet Rich Plasma (PRP2)
Musculoskeletal injuries and diseases are the main cause of disability in the U.S. Platelet Rich Plasma (PRP) is defined as an autologous blood…
2019-2021
image of LaTonya Hickson, MD
LaTonya Hickson, MD
Patient-derived Mesenchymal Stromal Cell Therapy in Diabetic Kidney Disease: A Phase I Study
Diabetic kidney disease (DKD) is the most common cause of kidney failure in the U.S. and has no adequate cure. Mesenchymal stromal cell (MSC)…
2019-2021
Troy C. Lund, MD, PhD
Accelerating hematopoietic cell regeneration
Successful bone marrow transplant is the only way to cure a number of cancers, bone marrow failure syndromes, and other serious blood disease (like…
2018-2020
image of Joseph Lillegard, MD, PhD
Joseph Lillegard, MD, Phd
Gene therapy of hereditary Tyrosinemia Type I using in vivo lentiviral vectors
Hereditary Tyrosinemia Type 1 (HT1) is a genetic disorder that can lead to liver and kidney failure, and is fatal without treatment. There is no…
2018-2020
image of Daniel Garry, MD, PhD
Daniel Garry, MD, PhD
Bioengineering strategies for cardiovascular disease and regeneration
Cardiovascular disease is the most common cause of death in the United States, and many patients need heart transplants to survive. Currently,…
2018-2020
image of Terence Burns, MD, PhD
Terrence C. Burns, MD, PhD
Safety and mechanisms of senolytic therapy for central nervous system rejuvenation
The decline of memory and thinking processes seen in aging, neurodegenerative diseases (like Alzheimer’s disease), and exposure of the brain to…
2018-2020
image of Raghavendra Rao, MD
Raghavendra Rao, MD
Neuroprotection Using Human Extremely Low Gestational Age Neonate-Derived Umbilical Cord Blood Stem Cells in Neonatal Hemorrhagic Brain Injury
Each year in the United States, 12,000 extremely preterm infants (birth before 28 weeks of pregnancy) develop bleeding within the brain soon after…
2018-2020
image of Robert Tranquillo, PhD
Robert Tranquillo, PhD
Regenerative vein valve
Millions of U.S. citizens suffer from vein valve insufficiency, often resulting in chronic leg ulcers that cause pain, immobility, and a reduced…
2018-2020